Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Zeitschrift für Naturforschung C

A Journal of Biosciences

Editor-in-Chief: Seibel, Jürgen

Editorial Board: Aigner , Achim / Boland, Wilhelm / Bornscheuer, Uwe / Hoffmann, Klaus

12 Issues per year


IMPACT FACTOR 2017: 0.882
5-year IMPACT FACTOR: 0.912

CiteScore 2017: 0.92

SCImago Journal Rank (SJR) 2017: 0.288
Source Normalized Impact per Paper (SNIP) 2017: 0.448

Online
ISSN
1865-7125
See all formats and pricing
More options …
Volume 55, Issue 9-10

Issues

Effect of Minor Components of Virgin Olive Oil on Topical Antiinflammatory Assays

Rocío de la Puerta / Eugenia Martínez-Domínguez / Valentina Ruíz-Gutiérrez
Published Online: 2014-06-02 | DOI: https://doi.org/10.1515/znc-2000-9-1023

Abstract

Interest in the health-promoting effects of virgin olive oil, an important part of the “Mediterranean diet”, prompted us to determine the antiinflammatory effects of erythrodiol, β-sitosterol and squalene, identified as major components of the so-called “unsaponifiable fraction” of virgin olive oil, as well as of the phenolic compounds from the “polar fraction”: oleuropein, tyrosol, hydroxytyrosol and caffeic acid. Their activities were compared to those of both, total unsaponifiable and polar fractions. This study was designed to analyse the antiinflammatory effect of these specific compounds from virgin olive oil on edema in mice induced by either arachidonic acid (AA ) or 12-O-tetradecanoylphorbol acetate (TPA). The inhibition of the myeloperoxidase (MPO), marker enzyme of the accumulation of neutrophils in the inflamed tissue, was also investigated by the TPA model. The topical application of the olive oil compounds (0.5 mg/ear) produced a variable degree of antiinflammatory effect with both assays. In the auricular edema induced by TPA, β-sitosterol and erythrodiol from the unsaponifiable fraction of the oil showed a potent antiedematous effect with a 61.4% and 82.1% of inhibition respectively, values not very different to that of the reference indomethacin (85.6%) at 0.5 mg/ear. The four phenolics exerted a similar range of inhibition (33- 45%). All compounds strongly inhibited the enzyme myeloperoxidase, indicating a reduction of the neutrophil influx in the inflamed tissues. The strongest inhibitor of AA edema was the total unsaponifiable fraction which inhibition was 34%, similar to that obtained by the reference drug dexamethasone at 0.05 mg/ear. Among the phenolics, oleuropein also produced an inhibition of about 30% with the same dose, but all the other components were found less active in this assay. The anti-inflammatory effects exerted by both unsaponifiable and polar compounds might contribute to the potential biological properties reported for virgin olive oil against different pathological processess.

Keywords: Unsaponifiable Compounds; Olive Oil Phenolics; Topical Ear Edema

About the article

Received: 2000-04-03

Revised: 2000-05-03

Published Online: 2014-06-02

Published in Print: 2000-10-01


Citation Information: Zeitschrift für Naturforschung C, Volume 55, Issue 9-10, Pages 814–819, ISSN (Online) 1865-7125, ISSN (Print) 0939-5075, DOI: https://doi.org/10.1515/znc-2000-9-1023.

Export Citation

© 1946 – 2014: Verlag der Zeitschrift für Naturforschung. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Rosalía Rodríguez-Rodríguez, María Dolores Herrera, Javier S. Perona, and Valentina Ruiz-Gutiérrez
British Journal of Nutrition, 2004, Volume 92, Number 04, Page 635
[2]
E.J. Buenz, H.E. Johnson, E.M. Beekman, T.J. Motley, and B.A. Bauer
Journal of Ethnopharmacology, 2005, Volume 96, Number 1-2, Page 57
[3]
Ahmet Cumaoğlu, Nuray Ari, Murat Kartal, and Çimen Karasu
Rejuvenation Research, 2011, Volume 14, Number 3, Page 325
[4]
Ana Henriques Mota, Catarina Oliveira Silva, Marisa Nicolai, André Baby, Lídia Palma, Patrícia Rijo, Lia Ascensão, and Catarina Pinto Reis
Pharmaceutical Development and Technology, 2017, Page 1
[5]
Walla'a A. Osman, Dina A. Labib, Mona O. Abdelhalim, and Elsayed M. Elrokh
International Journal of Rheumatic Diseases, 2017

Comments (0)

Please log in or register to comment.
Log in